pamidronate has been researched along with Skin Neoplasms in 4 studies
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the protective effect of apigenin against growth inhibition of normal epithelial human prostatic (PNT2), transgenic adenocarcinoma of mouse prostate (TRAMP-C1) and metastatic melanoma cells (B16F10) in combined treatments with bisphosphonates and ionizing radiation (IR)." | 3.79 | Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines. ( Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Olivares, A, 2013) |
| "Cutaneous melanoma is one of the highly malignant human tumours, due to its tendency to generate early metastases and its resistance to classical chemotherapy." | 1.32 | Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells. ( Forsea, AM; Geilen, CC; Müller, C; Orfanos, CE; Riebeling, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, M | 1 |
| Olivares, A | 1 |
| Achel, DG | 1 |
| Alcaraz-Saura, M | 1 |
| Forsea, AM | 1 |
| Müller, C | 1 |
| Riebeling, C | 1 |
| Orfanos, CE | 1 |
| Geilen, CC | 1 |
| Ramadan, KM | 1 |
| McKenna, KE | 1 |
| Morris, TC | 1 |
| Nakaguchi, K | 1 |
| Furukawa, J | 1 |
| Shingai, T | 1 |
| Azama, T | 1 |
| Yoshioka, S | 1 |
| Katsumoto, Y | 1 |
| Morimoto, T | 1 |
| Okajima, S | 1 |
| Sue, F | 1 |
4 other studies available for pamidronate and Skin Neoplasms
| Article | Year |
|---|---|
Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines.
Topics: Animals; Antioxidants; Apigenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modal | 2013 |
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
Topics: Antimetabolites; Antineoplastic Agents; Cell Cycle; Clodronic Acid; Diphosphonates; Disease Progress | 2004 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bor | 2006 |
[A case of multiple bone metastases from advanced breast cancer effectively treated with pamidronate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; | 1999 |